Mirum Pharmaceuticals Inc (MIRM)
26.40
+0.56
(+2.17%)
USD |
NASDAQ |
May 06, 16:00
26.40
0.00 (0.00%)
After-Hours: 16:54
Mirum Pharmaceuticals Total Assets (Quarterly): 646.62M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 646.62M |
| September 30, 2023 | 650.64M |
| June 30, 2023 | 443.59M |
| March 31, 2023 | 333.53M |
| December 31, 2022 | 352.91M |
| September 30, 2022 | 364.35M |
| June 30, 2022 | 297.23M |
| March 31, 2022 | 278.15M |
| December 31, 2021 | 294.65M |
| September 30, 2021 | 235.17M |
| Date | Value |
|---|---|
| June 30, 2021 | 247.67M |
| March 31, 2021 | 222.24M |
| December 31, 2020 | 240.86M |
| September 30, 2020 | 141.86M |
| June 30, 2020 | 155.77M |
| March 31, 2020 | 172.80M |
| December 31, 2019 | 146.71M |
| September 30, 2019 | 158.27M |
| June 30, 2019 | 104.27M |
| March 31, 2019 | 51.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
104.27M
Minimum
Jun 2019
650.64M
Maximum
Sep 2023
288.80M
Average
247.67M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | 648.44M |
| Sarepta Therapeutics Inc | 3.224B |
| Puma Biotechnology Inc | 230.53M |
| Reneo Pharmaceuticals Inc | 107.44M |
| Tharimmune Inc | 10.95M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 397.95M |
| Shareholders Equity (Quarterly) | 248.67M |
| Debt to Equity Ratio | 1.232 |
| Current Ratio | 4.451 |
| Net Debt Paydown Yield | -4.44% |